AlphAIAlphAI — Financial news for AI agents
scanx.tradeSEP 152 min read$CHWY

Chewy rises as Goldman Sachs maintains Buy rating on stock

Chewy Inc. shares rose 6.78% to $19.06 after Goldman Sachs maintained a Buy rating but lowered its price target to $34 from $46. The company reported Q1 earnings beat but reduced its fiscal 2026 sales outlook, prompting multiple analysts to cut price targets. Chewy's stock is down 56.34% over the past year and trades near its 52-week low.

Original reporting
scanx.trade
Published Sep 15, 2026, 2:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Chewy rises as Goldman Sachs maintains Buy rating on stock — source image
Source · scanx.trade
Decision brief

The 30-second read

$CHWYBullishMed
01

Why it matters

The mixed signal of earnings beat versus weaker outlook creates volatility; traders may focus on price‑target revisions and technical support levels.

02

Market read

Chewy's price action and analyst revisions highlight a short‑term trading opportunity within the consumer discretionary sector.

03

What to watch

Weak revenue outlook for FY2026 and a death‑cross technical pattern suggest downside risk.

Relevance 7/10Novelty 7/10Timing: today

Background

Chewy reported Q1 earnings beat but trimmed FY2026 sales guidance; multiple analysts cut targets while keeping bullish ratings.

Company-level read

Ticker impact

$CHWYBullishMedium confidence
Context

Goldman Sachs kept a Buy rating on Chewy, cut its price target to $34 and the stock jumped 6.78% to $19.06.

Expected impact

Near‑term price could rise toward $20‑$22 if buying pressure continues.

Evidence & confidence

Analyst consensus remains Buy despite lower targets, and the stock is trading near its 20‑day SMA support.

Market effects

Sector

Consumer discretionary pet‑retail segment may see modest gains as Chewy rebounds.

Regional

U.S. market participants may view the move as a sign of resilience in e‑commerce.

Global

Limited to U.S. equities; no broader macro impact.

Counterpoint

What could challenge this read

Lowered price targets signal weakening fundamentals; the rally could be short‑lived.

Key entities

  • Analyst
    Goldman Sachs

    Maintained Buy rating, reduced price target to $34.

  • Company
    Chewy Inc

    Online pet retailer that posted Q1 earnings beat and lowered FY2026 guidance.

Read at source← All news

Related articles

SEP 24
$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

247wallst.com3 min
SEP 18
$CHWYMed

Chewy Puts a $50 Million Price Tag on AI Productivity

Chewy expects AI to reduce costs by $50M in fiscal 2027, up from low tens of millions this year. CEO Sumit Singh attributes savings to AI tools in customer service, pharmacy, and veterinary care. The company's AI assistant, Cai, handles 30% of chats without human agents. AI tools also improve internal operations and pharmacy processes. Chewy built the AI infrastructure in-house, giving it a competitive advantage. The savings will offset wage inflation and fund growth initiatives.

pymnts.com2 min
SEP 14
$CHWYMedAI 8/10

CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom?

Chewy (CHWY) shares rose 6% to $21.75, despite a 34% YTD decline. The company reported 7.3% sales growth, raised full-year revenue guidance, and maintained gross margin at 30.4%. Cash decreased to $611M due to acquisitions and share buybacks. The broader pet-care sector has underperformed, with the PAWZ ETF down 10% YTD. Investors await Q3 2026 results to assess margin expansion and potential bottom.

247wallst.com2 min
SEP 13
$CHWYMedAI 8/10

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy (CHWY) reported Q2 2026 net sales of $3.33B, up 7.3%, and adjusted EPS of $0.36. The company raised its full-year outlook, but analysts downgraded the stock and cut price targets. CHWY stock fell 10% intraday after the results. Active customers rose 3.8% to 21.7M. Organic revenue growth slowed to 5.7%, and adjusted EBITDA margin benefited from non-recurring items. Analysts debate whether the slowdown is cyclical or structural.

yahoo.com2 min
SEP 11
$CHWYMedAI 8/10

CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook

Chewy Inc. (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, meeting estimates. Adjusted EPS rose to $0.36, missing estimates by 1%. Gross margin remained unchanged at 30.4%, while adjusted EBITDA increased 23.7% to $226.7M. Chewy raised its FY26 revenue outlook but narrowed EBITDA margin guidance. CHWY stock fell 7% in morning trade, hitting a one-month low.

stocktwits.com2 min
SEP 11
$CHWYHighAI 9/10

Chewy (CHWY) Is Building a Recurring Revenue Moat Through Autoship and a Vet Care Health Platform

Chewy (CHWY) reported Q2 FY2026 revenue of $3.33B, up 7.3% YoY, with Autoship sales at 84.6% of total. Active customers grew 3.8% YoY to 21.7M. Gross margin was 30.4%, and net income was $80.5M. Management raised full-year guidance, targeting $13.46B-$13.57B in net sales. Chewy Health and Vet Care showed strong growth, with 47 clinics and plans for 10-12 more.

news.alphastreet.com3 min